Get started
Author

Eleftheria Tampouratzi

Observed names: E Tampouratzi, E. Tampouratzi, Eleftheria Tampouratzi*, Leftheria Tampouratzi, Tampouratzi Eleftheria, Tampouratzi Ε, Tampouratzi, Eleftheria
ORCID: 0000-0002-3025-5085
Observed ORCID: 0000-0002-3025-5085
OpenAlex ID: A5070312126
Case report: Treating a combination of hidradenitis suppurativa and psoriasis with different therapeutic approaches
2019 · Eleftheria Tampouratzi, Theodora Kanni, et al. · F1000Research · 14
PDF
A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘ APRAISAL ’ study
2022 · D. Ioannides, N. Antonakopoulos, et al. · Journal of the European Academy of Dermatology and Venereology · 12
Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches
2020 · Eleftheria Tampouratzi, Theodora Kanni, et al. · F1000Research · 12
Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals
2022 · Eleftheria Tampouratzi, Markos Papakonstantis, et al. · Dermatologic Therapy · 11
Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
2024 · Dimitrios Rigopoulos, Eleftheria Tampouratzi, et al. · Journal of the European Academy of Dermatology and Venereology · 9
PDF
Real world experience of brodalumab treatment in patients with moderate‐to‐severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study
2022 · Dimitrios Rigopoulos, Charalampos Angelakopoulos, et al. · Dermatologic Therapy · 8
PDF
Epidemiologic characteristics of de novo versus nevus-associated melanoma
2025 · Maria Kostaki, Georgios Porfiriou, et al. · Melanoma Research · 2
Brodalumab Seems to Recover Its Therapeutic Efficacy After a Relatively Short "Washout" Period with Anti-TNF Agents: A Successful Pattern for Double-switch Therapy.
2023 · Eleftheria Tampouratzi, Konstantinos Sfaelos, et al. · PubMed · 2
PDF
165 Scalp, palmoplantar, and nail involvement in moderate bio-naive psoriasis patients treated with apremilast: 6-week interim results of a real-world, multicenter, prospective study in Greece
2019 · D. Ioannides, E. Tampouratzi, et al. · Journal of Investigative Dermatology · 2
Multifactorial Evaluation of Mesotherapy with an Innovative Hyaluronic Acid Skin Booster
2025 · Eleftheria Tampouratzi, Eirini Nektaria Giagkou, et al. · Journal of Skin and Stem Cell · 1
Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
2024 · E Tampouratzi, K Sfaelos, et al. · Dermatology The American Medical Journal · 1
PDF
Acrodermatitis Continua of Hallopeau Evolving into Psoriatic Monoarthritis: Successfully Treated with Apremilast.
2024 · Tampouratzi Eleftheria, Giagkou Eirini-Nektaria, et al. · PubMed · 1
A 52-Week Split-Face Study on the Efficacy and Safety of a New-Type Hyaluronic Acid Injectable Filler for Nasolabial Wrinkles
2023 · Eleftheria Tampouratzi, Maria Kostaki, et al. · Journal of Skin and Stem Cell · 1
PDF
Rosacea and Helicobacter pylori, is there any Relationship?
2020 · Tampouratzi Ε, Michalopoulos G, et al. · Archives of Surgical Dermatology · 1
PDF
Modified Mercedes flap – an effective reconstructive option for lower leg skin defects
2019 · Eleftheria Tampouratzi, Theodora Kanni, et al. · Journal of Dermatological Treatment · 1
An Unusual Late Onset of Ichthyosis Hystrix.
2018 · Eleftheria Tampouratzi, Eftychia Platsidaki, et al. · PubMed · 1
42 Comparing the clinical profile with immunohistochemistry in psoriasis treatment with interleukin 17RA inhibitor using survivin as a biomarker
2025 · Eleftheria Tampouratzi, Konstantinos Sfaelos, et al. · Journal of Investigative Dermatology
PDF
Using Conjoint Analysis to Elicit Benefit–Risk Preferences for Different Treatment Options Among Psoriasis Patients Receiving Systemic Therapy
2025 · Antonios Tsartsarakis, Eleftheria Tampouratzi, et al. · Therapeutics
PDF
Tear Trough Deformity Refinement by an Innovative Hyaluronic Acid Injectable Filler
2025 · Eleftheria Tampouratzi, Eirini Nektaria Giagkou, et al. · Journal of Skin and Stem Cell
PDF
Erratum for A 52-Week Split-Face Study on the Efficacy and Safety of a New-Type Hyaluronic Acid Injectable Filler for Nasolabial Wrinkles [J Skin Stem Cell. 2023; 10 (4): e139438]
2025 · Eleftheria Tampouratzi, Maria Kostaki, et al. · Journal of Skin and Stem Cell
PDF
Erythromelalgia: An unusual cutaneous manifestation of HSV infection? A case report
2025 · Theodora Douvali, Leftheria Tampouratzi, et al. · Our Dermatology Online
PDF
A Case Report of Metastatic Retroperitoneal Angiosarcoma Mimicking Reactive Angioendotheliomatosis
2025 · Theodora Douvali, Georgios Sarris, et al. · Cureus
Εffects of vitamin C, silicone gel, and their combination on small- and medium-sized dermatological trauma healing: a prospective study
2025 · Eleftheria Tampouratzi, Ioannis Karavokyros, et al. · Review of Clinical Pharmacology and Pharmacokinetics - International Edition
Survivin as a Promising Biomarker for Patients Under IL17 RA Inhibitor Therapy: A Single‐Center, Pilot Study
2025 · Eleftheria Tampouratzi, John Katsantonis, et al. · Dermatologic Therapy
PDF
Trilateral Blaschkoid linear lichen planus associated with COVID-19 vaccination
2024 · Theodora Douvali, Eleni Zachariadou, et al. · Our Dermatology Online
PDF
Works count: 44
Citation count: 80
H-index: 6
I10-index: 4
Year
Topic
Type